Feedback

Systems biology reveals anatabine to be an NRF2 activator

Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Messinis, Dimitris E.;
Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Poussin, Carine;
Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Latino, Diogo A. R. S.;
Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Eb-Levadoux, Yvan;
Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Dulize, Remi;
Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Peric, Dariusz;
Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Guedj, Emmanuel;
Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Titz, Bjoern;
Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Ivanov, Nikolai V.;
Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Peitsch, Manuel C.;
Affiliation
PMI R&D ,Philip Morris Products S.A ,Neuchâtel ,Switzerland
Hoeng, Julia

Anatabine, an alkaloid present in plants of the So lanaceae family (including tobacco and eggplant), has been shown to ameliorate chronic inflammatory conditions in mouse models, such as Alzheimer’s disease, Hashimoto’s thyroiditis, multiple sclerosis, and intestinal inflammation. However, the mechanisms of action of anatabine remain unclear. To understand the impact of anatabine on cellular systems and identify the molecular pathways that are perturbed, we designed a study to examine the concentration-dependent effects of anatabine on various cell types by using a systems pharmacology approach. The resulting dataset, consisting of measurements of various omics data types at different time points, was analyzed by using multiple computational techniques. To identify concentration-dependent activated pathways, we performed linear modeling followed by gene set enrichment. To predict the functional partners of anatabine and the involved pathways, we harnessed the LINCS L1000 dataset’s wealth of information and implemented integer linear programming on directed graphs, respectively. Finally, we experimentally verified our key computational predictions. Using an appropriate luciferase reporter cell system, we were able to demonstrate that anatabine treatment results in NRF2 (nuclear factor-erythroid factor 2-related factor 2) translocation, and our systematic phosphoproteomic assays showed that anatabine treatment results in activation of MAPK signaling. While there are certain areas to be explored in deciphering the exact anti-inflammatory mechanisms of action of anatabine and other NRF2 activators, we believe that anatabine constitutes an interesting molecule for its therapeutic potential in NRF2-related diseases.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2022 Messinis, Poussin, Latino, Eb-Levadoux, Dulize, Peric, Guedj, Titz, Ivanov, Peitsch and Hoeng.

Use and reproduction: